Dreluso Pharmazeutika Dr. Elten und Sohn GmbH - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor amisulpride amisulpride 400 mg uncoated tablet blister pack

southern cross pharma pty ltd - amisulpride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor amisulpride amisulpride 200 mg uncoated tablet blister pack

southern cross pharma pty ltd - amisulpride -

Australia - English - Department of Health (Therapeutic Goods Administration)

sulprix amisulpride 50 mg tablets blister pack

alphapharm pty ltd - amisulpride, quantity: 50 mg - tablet - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; lactose monohydrate; hypromellose - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

amisulpride sandoz 400 amisulpride 400 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride -

Australia - English - Department of Health (Therapeutic Goods Administration)

amisulpride sandoz 200 amisulpride 200 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride -

Australia - English - Department of Health (Therapeutic Goods Administration)

amisulpride sandoz 100 amisulpride 100 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride -